F/M Investments »

Miragen Therapeutics shares owned by F/M Investments

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by F/M Investments from 13F filings

Historical chart of F/M Investments investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by F/M Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by F/M Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.5M 135k 18.37

More positions owned by F/M Investments

Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Invesco Exch Traded Fd Tr Ii Short Term Treas (TBLL)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Apple (AAPL)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
RBB F/m Us Treasury (TBIL)
RBB Fm Opportunistic (ZHOG)
Palo Alto Networks (PANW)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)

View all positions for F/M Investments

Top funds holding Miragen Therapeutics

FMR
BlackRock
Bellevue Group
Paradigm Biocapital Advisors
Kynam Capital Management
Fairmount Funds Management
State Street Corporation
Vanguard Capital Management
Deep Track Capital
VR Adviser
T. Rowe Price Associates
Wellington Management Company
Vanguard Portfolio Management
Geode Capital Management
venBio Select Advisor

View all funds holding Miragen Therapeutics